Vertex Pharmaceuticals Inc / Ma paid its 6 named executives $59.8M in total in FY2025 (Dec). CEO Reshma Kewalramani was paid $21.1M of that.
Pay$100 in the stock at the end of FY20 → $192
Pay of each named executive
Reshma KewalramaniCEO and President
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Stuart A. ArbuckleEVP & Chief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Charles F. Wagner, Jr.EVP & Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Nia TatsisEVP & Chief Regulatory and Quality Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Amit SachdevEVP & Chief Patient and External Affairs Officer
| FY2025 (Dec) |
1 year
Carmen BozicEVP & Chief Medical Officer
| FY2025 (Dec) |
1 year
CEO pay against the pay peers
In FY2024 (Dec), the median CEO pay of the 8 peers with pay on file was $21.2M. The CEO of Vertex Pharmaceuticals Inc / Ma was paid $21.5M, 1% above the median.
- 1Eli Lilly & Co
- 2Amgen
- 3Biogen
- 4Gilead Sciences
- 5Vertex Pharmaceuticals Inc / MaThis company
- 6Bristol Myers Squibb
- 7AbbVie
- 8Incyte
- 9Regeneron Pharmaceuticals
- 10Alnylam PharmaceuticalsNot disclosed
- 11BioMarin Pharmaceuticals, Inc.Not disclosed
- 12Jazz Pharmaceuticals plcNot disclosed
- 13ModernaNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.